Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine

被引：28

作者：

Chao, KSC

Ozyigit, G

Thorsdad, WL

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA

[2] Washington Univ, Ctr Med, Dept Radiat Oncol, St Louis, MO USA

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 06期

关键词：

D O I：

10.1053/j.seminoncol.2003.11.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：101 / 108

页数：8

共 31 条

[1] Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer [J].

Antonadou, D ;

Pepelassi, M ;

Synodinou, M ;

Puglisi, M ;

Throuvalas, N .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :739-747

[2] RADIATION-THERAPY OF THE ORAL CAVITY - SEQUELAE AND MANAGEMENT .2. [J].

BEUMER, J ;

CURTIS, T ;

HARRISON, RE .

HEAD & NECK SURGERY, 1979, 1 (05) :392-408

[3] RADIATION-THERAPY OF THE ORAL CAVITY - SEQUELAE AND MANAGEMENT .1. [J].

BEUMER, J ;

CURTIS, T ;

HARRISON, RE .

HEAD & NECK SURGERY, 1979, 1 (04) :301-312

[4] A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma [J].

Bourhis, J ;

De Crevoisier, R ;

Abdulkarim, B ;

Deutsch, E ;

Lusinchi, A ;

Luboinski, B ;

Wibault, P ;

Eschwege, F .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (05) :1105-1108

[5] Intensity-modulated radiotherapy: Current status and issues of interest [J].

Boyer, AL ;

Butler, EB ;

DiPetrillo, TA ;

Engler, MJ ;

Fraass, B ;

Grant, W ;

Ling, CC ;

Low, DA ;

Mackie, TR ;

Mohan, R ;

Purdy, JA ;

Roach, M ;

Rosenman, JG ;

Verhey, LJ ;

Wong, JW ;

Cumberlin, RL ;

Stone, H ;

Palta, JR .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :880-914

[6] Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: Subcutaneous amifostine and computed tomography-based target delineation [J].

Braaksma, M ;

Levendag, P .

SEMINARS IN ONCOLOGY, 2002, 29 (06) :63-70

[7] Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J].

Brizel, DM ;

Wasserman, TH ;

Henke, M ;

Strnad, V ;

Rudat, V ;

Monnier, A ;

Eschwege, F ;

Zhang, J ;

Russell, L ;

Oster, W ;

Sauer, R .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3339-3345

[8] Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis [J].

Browman, GP ;

Hodson, DI ;

Mackenzie, RJ ;

Bestic, N ;

Zuraw, L .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (07) :579-589

[9] Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer [J].

Buntzel, J ;

Kuttner, K ;

Frohlich, D ;

Glatzel, M .

ANNALS OF ONCOLOGY, 1998, 9 (05) :505-509

[10] Smart (simultaneous modulated accelerated radiation therapy) boost: A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy [J].

Butler, EB ;

Teh, BS ;

Grant, WH ;

Uhl, BM ;

Kuppersmith, RB ;

Chiu, JK ;

Donovan, DT ;

Woo, SY .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01) :21-32

← 1 2 3 4 →